Company news
Neuroscientific Biopharmaceuticals Ltd. news in 2020
Neuroscientific Biopharmaceuticals Ltd.'s news releases, calls and decks from 2020, newest first.
NSB to investigate treatment for post-COVID Fibrosis
November 20, 2020
Strategic Placement to AlphaSwiss Partners
November 11, 2020
Appendix 4E and Annual Report
August 28, 2020
Updated Appendix 4C
August 11, 2020
Full Report from Multiple Sclerosis Study
August 3, 2020
EmtinB Positive Results in MS
July 13, 2020
Final Report received for Glaucoma Study
May 4, 2020
Positive Results in MS Study
March 17, 2020
Positive Results in Glaucoma Pig Model
March 10, 2020
Additional US Patent granted
January 21, 2020
Decks in 2020
- Australia Biotech + Invest 2020
Conference · 25 slides · Oct 28, 2020
- Westar Capital Investor Evening (August 2020)
Conference · 24 slides · Aug 26, 2020
- Techknow Invest Roadshow Webinar (May 2020)
Conference · 21 slides · May 20, 2020